Form 4: ICU Medical COO Christian Voigtlander Reports Stock Transactions Following Vesting of Restricted Stock Units
SEC Form 4
Christian Voigtlander, COO of ICU Medical, reports acquisition and disposal of common stock following the vesting of restricted stock units and performance-based restricted stock units.
Summary
- Christian Voigtlander, the Chief Operating Officer of ICU Medical, reported transactions involving the company's common stock.
- On March 7th and 8th, 2024, Voigtlander acquired shares through the vesting of Restricted Stock Units (RSUs) and Performance-based Restricted Stock Units (PRSUs).
- Simultaneously, Voigtlander disposed of shares to cover tax obligations related to the vesting of these units.
- The transactions involved both RSUs and PRSUs, with vesting percentages determined by the Compensation Committee based on performance metrics.
- The price per share for the disposed shares was $105.39 on March 7th and $104.52 on March 8th.
- Following these transactions, Voigtlander still beneficially owns a significant number of ICU Medical's common stock.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the vesting of performance-based stock units at above-target levels, suggesting strong company performance. However, the disposal of shares to cover tax obligations is a neutral event.
Positives
- The vesting of PRSUs at 200% and 110% indicates that performance metrics were likely met or exceeded, reflecting positively on the company's performance.
- Continued ownership of a significant number of shares by the COO aligns his interests with those of the shareholders.
Industry Context
Executive compensation in the healthcare industry often includes stock-based awards like RSUs and PRSUs to align management's interests with shareholder value.
Comparison to Industry Standards
- Stock-based compensation is a common practice among publicly traded companies, including ICU Medical's competitors such as Becton Dickinson, Baxter International, and Medtronic.
- Vesting schedules and performance metrics for PRSUs are typically designed to incentivize specific company goals, such as revenue growth, profitability, or market share gains.
- The vesting percentages of 200% and 110% for the PRSUs suggest that ICU Medical's performance exceeded the initial targets set by the Compensation Committee, which is a positive indicator compared to industry peers.
Stakeholder Impact
- Shareholders may view the vesting of PRSUs positively, as it indicates that the company has met or exceeded performance goals.
- Employees may be motivated by the potential for similar performance-based rewards in the future.
Key Dates
| Date | Description |
|---|---|
| 03/08/2021 | Date of grant for PRSUs that had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. |
| 03/07/2022 | Date of grant for PRSUs that had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. |
| 03/07/2023 | One third of the units subject to the RSU award shall vest on each of the first, second, and third anniversaries of the grant date. |
| 03/07/2024 | Date of transactions involving vesting of RSUs and PRSUs, and disposal of shares for tax obligations. |
| 03/08/2024 | Date of transactions involving vesting of RSUs and PRSUs, and disposal of shares for tax obligations. |
| 03/11/2024 | Date of signature on the Form 4 filing. |
| 03/07/2025 | These are restricted stock units that fully vest 3 years from the grant date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.